Strategic direction, page-2

"Currently known three wearable programs Sanofi, Mefimmune, Amgem."


Mate that's the starting point from here on out imo. Add to that new Wearable customers and that is the roadmap, with the other programs we shall find out what they are to do going forward. I suspect a certain upfront of some sorts and possible licensing for the PFS programs, they are worth money to others who are already in the game and are able to sink the money into meeting those minimum amounts to manufacture, staff and then ramp.

The AI is an interesting one for me as I'm not sure if it goes with the PFS and Ocular all bundled up, lol, we wait for that!